Skip to main content
. 2023 Jan 31;92(6):671–682. doi: 10.1134/S1019331622060041

Fig. 3.

Fig. 3.

Development of the peptide drug RAS70 against membrane-bound Hsp70 on cancer cells for targeted intraoperative diagnosis of malignant neoplasms.